NANO MRNA Co.,Ltd. 3NQ.F Stock
NANO MRNA Co.,Ltd. Price Chart
NANO MRNA Co.,Ltd. 3NQ.F Financial and Trading Overview
| NANO MRNA Co.,Ltd. stock price | 0.75 EUR |
| Previous Close | 1.39 EUR |
| Open | 1.39 EUR |
| Bid | 1.4 EUR x 22300 |
| Ask | 1.47 EUR x 21000 |
| Day's Range | 1.39 - 1.4 EUR |
| 52 Week Range | 1.1 - 1.97 EUR |
| Volume | 9 EUR |
| Avg. Volume | 37 EUR |
| Market Cap | 99.24M EUR |
| Beta (5Y Monthly) | 0.544444 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3NQ.F Valuation Measures
| Enterprise Value | -3234700800 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.4912759 |
| Price/Book (mrq) | 0.023088213 |
| Enterprise Value/Revenue | -16.013 |
| Enterprise Value/EBITDA | N/A |
Trading Information
NANO MRNA Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.544444 |
| 52-Week Change | -10.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.97 EUR |
| 52 Week Low | 1.1 EUR |
| 50-Day Moving Average | 1.49 EUR |
| 200-Day Moving Average | 1.39 EUR |
3NQ.F Share Statistics
| Avg. Volume (3 month) | 37 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 70.15M |
| Float | 64.13M |
| Short Ratio | N/A |
| % Held by Insiders | 9.07% |
| % Held by Institutions | 3.77% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 100:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -616.83% |
| Gross Margin | 78.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 202M EUR |
| Revenue Per Share (ttm) | 2.88 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 160M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1310000000 EUR |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.44B EUR |
| Total Cash Per Share (mrq) | 63.35 EUR |
| Total Debt (mrq) | 1.11B EUR |
| Total Debt/Equity (mrq) | 26.05 EUR |
| Current Ratio (mrq) | 12.824 |
| Book Value Per Share (mrq) | 60.637 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1087000064 EUR |
| Levered Free Cash Flow (ttm) | N/A |
Profile of NANO MRNA Co.,Ltd.
| Country | Germany |
| State | N/A |
| City | Tokyo |
| Address | Onoya-Kyobashi Building |
| ZIP | 104-0031 |
| Phone | 81 3 3241 0550 |
| Website | https://www.nanocarrier.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
NanoCarrier Co., Ltd. researches, develops, produces, and sells pharmaceuticals using micelle nanoparticle technology primarily for the treatment of cancer in Japan. The company's pipeline products includes ENT103, an antibacterial eardrops for the treatment of otitis media; NC-6300 Epirubicin micelle that is in phase I clinical trials; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma and RUNX1 (mRNA) for osteoarthritis of the knee that are in preclinical stage. The company was incorporated in 1996 and is headquartered in Tokyo, Japan.
Q&A For NANO MRNA Co.,Ltd. Stock
What is a current 3NQ.F stock price?
NANO MRNA Co.,Ltd. 3NQ.F stock price today per share is 0.75 EUR.
How to purchase NANO MRNA Co.,Ltd. stock?
You can buy 3NQ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NANO MRNA Co.,Ltd.?
The stock symbol or ticker of NANO MRNA Co.,Ltd. is 3NQ.F.
Which industry does the NANO MRNA Co.,Ltd. company belong to?
The NANO MRNA Co.,Ltd. industry is Biotechnology.
How many shares does NANO MRNA Co.,Ltd. have in circulation?
The max supply of NANO MRNA Co.,Ltd. shares is 98.69M.
What is NANO MRNA Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
NANO MRNA Co.,Ltd. PE Ratio is now.
What was NANO MRNA Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
NANO MRNA Co.,Ltd. EPS is -0.09 EUR over the trailing 12 months.
Which sector does the NANO MRNA Co.,Ltd. company belong to?
The NANO MRNA Co.,Ltd. sector is Healthcare.